Patient Context and Thyrotropin Levels Are Important When Considering Treatment of Subclinical Hypothyroidism
Thyroid
.
2019 Oct;29(10):1359-1363.
doi: 10.1089/thy.2019.0494.
Epub 2019 Oct 3.
Authors
Anna M Sawka
1
,
Anne R Cappola
2
,
Robin P Peeters
3
,
Peter A Kopp
4
5
,
Antonio C Bianco
6
,
Jacqueline Jonklaas
7
Affiliations
1
Division of Endocrinology, University Health Network and University of Toronto, Toronto, Canada.
2
Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
3
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
4
Division of Endocrinology, University of Lausanne, Lausanne, Switzerland.
5
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, Illinois.
6
Section of Endocrinology and Metabolism, University of Chicago, Chicago, Illinois.
7
Division of Endocrinology, Georgetown University, Washington, District of Columbia.
PMID:
31489828
DOI:
10.1089/thy.2019.0494
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Hypothyroidism*
Quality of Life*
Thyroid Hormones
Thyrotropin
Substances
Thyroid Hormones
Thyrotropin